Tempest Therapeutics, Inc. (TPST)
NASDAQ: TPST · Real-Time Price · USD
9.95
+0.83 (9.10%)
Nov 5, 2025, 4:00 PM EST - Market closed
Tempest Therapeutics Market Cap
Tempest Therapeutics has a market cap or net worth of $44.18 million as of November 6, 2025. Its market cap has increased by 59.33% in one year.
Market Cap
44.18M
Enterprise Value
45.07M
1-Year Change
59.33%
Ranking
Category
Stock Price
$9.95
Market Cap Chart
Since June 28, 2021, Tempest Therapeutics's market cap has decreased from $88.65M to $44.18M, a decrease of -50.16%. That is a compound annual growth rate of -14.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 4, 2025 | 40.49M | 11.19% |
| Dec 31, 2024 | 36.42M | -57.00% |
| Dec 29, 2023 | 84.69M | 600.22% |
| Dec 30, 2022 | 12.09M | -66.85% |
| Dec 31, 2021 | 36.49M | -58.84% |
| Jun 28, 2021 | 88.65M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 811.99B |
| Johnson & Johnson | 450.20B |
| AbbVie | 381.56B |
| UnitedHealth Group | 299.68B |
| AstraZeneca | 253.45B |
| Novartis AG | 240.68B |
| Abbott Laboratories | 218.75B |
| Novo Nordisk | 215.64B |